Clinical Trials Logo

Clinical Trial Summary

To confirm the benefit of endoscopic resection under fluorescence and blue light of high grade non-muscle invasive bladder tumor, and verifying if the second endoscopic resection recommended nowadays can be deleted.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01750970
Study type Interventional
Source Hopital Foch
Contact
Status Completed
Phase N/A
Start date November 2009
Completion date December 2013

See also
  Status Clinical Trial Phase
Recruiting NCT04081246 - Transurethral Modified En Bloc Resection For Large Bladder Tumours. N/A
Recruiting NCT03331705 - Assessment of the Uro-C Cystoscope for Use in Diagnostic Cystoscopy Procedures N/A
Completed NCT04310813 - Microscopic-spectroscopic Examination for Urothelial Tissue Characterization
Unknown status NCT01826565 - Comparison of Two Insertion Technique of I-gel N/A
Completed NCT01665586 - Effective Dose of Dexmedetomidine for Sedation in Patients Undergoing TURP/TURB Under Spinal Anesthesia With or Without Fentanyl by Age Groups: Randomized Comparative Study N/A
Recruiting NCT03221829 - A Retrospective Analysis of Spinal Anaesthesia for TURBT Procedures in Elderly Patients N/A
Recruiting NCT05872451 - Current Intensity for the Obturator Nerve Block N/A
Recruiting NCT03029676 - The Assessment of POCD After TURBT Under Spinal Anesthesia Phase 4
Completed NCT04209114 - A Study of Nivolumab Plus Bempegaldesleukin (Bempeg/NKTR-214) vs Nivolumab Alone vs Standard of Care in Participants With Bladder Cancer That May Have Invaded The Muscle Wall of the Bladder and Who Cannot Get Cisplatin, A Type of Medicine Given To Treat Bladder Cancer Phase 3
Recruiting NCT04638569 - Comparison of Obturator Nerve Block With Ultrasound Guidance and Anatomical Signs N/A
Recruiting NCT06033040 - Medical Imaging in Bladder Tumors by MRI
Withdrawn NCT03517995 - Randomized, Phase II Clinical Trial of Sulforaphane in Bladder Cancer Chemoprevention Phase 2